These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25350788)

  • 21. Mutation, cell kinetics, and subpopulations at risk for colon cancer in the United States.
    Herrero-Jimenez P; Thilly G; Southam PJ; Tomita-Mitchell A; Morgenthaler S; Furth EE; Thilly WG
    Mutat Res; 1998 May; 400(1-2):553-78. PubMed ID: 9685710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Only three driver gene mutations are required for the development of lung and colorectal cancers.
    Tomasetti C; Marchionni L; Nowak MA; Parmigiani G; Vogelstein B
    Proc Natl Acad Sci U S A; 2015 Jan; 112(1):118-23. PubMed ID: 25535351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Diffusion-like Process Accommodates New Crypts During Clonal Expansion in Human Colonic Epithelium.
    Olpe C; Khamis D; Chukanova M; Skoufou-Papoutsaki N; Kemp R; Marks K; Tatton C; Lindskog C; Nicholson A; Brunton-Sim R; Malhotra S; Ten Hoopen R; Stanley R; Winton DJ; Morrissey E
    Gastroenterology; 2021 Aug; 161(2):548-559.e23. PubMed ID: 33895166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evolutionary landscape of colorectal tumorigenesis.
    Cross W; Kovac M; Mustonen V; Temko D; Davis H; Baker AM; Biswas S; Arnold R; Chegwidden L; Gatenbee C; Anderson AR; Koelzer VH; Martinez P; Jiang X; Domingo E; Woodcock DJ; Feng Y; Kovacova M; Maughan T; ; Jansen M; Rodriguez-Justo M; Ashraf S; Guy R; Cunningham C; East JE; Wedge DC; Wang LM; Palles C; Heinimann K; Sottoriva A; Leedham SJ; Graham TA; Tomlinson IPM
    Nat Ecol Evol; 2018 Oct; 2(10):1661-1672. PubMed ID: 30177804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update of genetics in colorectal carcinomas: genomic instability and somatic evolution.
    Cheah PY; Eu KW; Seow FC
    Ann Acad Med Singap; 2000 May; 29(3):331-6. PubMed ID: 10976386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evolutionary paradigm for carcinogenesis?
    Vineis P; Matullo G; Manuguerra M
    J Epidemiol Community Health; 2003 Feb; 57(2):89-95. PubMed ID: 12540682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant transformation and genetic alterations are uncoupled in early colorectal cancer progression.
    Mamlouk S; Simon T; Tomás L; Wedge DC; Arnold A; Menne A; Horst D; Capper D; Morkel M; Posada D; Sers C; Bläker H
    BMC Biol; 2020 Sep; 18(1):116. PubMed ID: 32895052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mathematical model for cancer risk and accumulation of mutations caused by replication errors and external factors.
    Uchinomiya K; Tomita M
    PLoS One; 2023; 18(6):e0286499. PubMed ID: 37315031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level.
    Macartney-Coxson DP; Hood KA; Shi HJ; Ward T; Wiles A; O'Connor R; Hall DA; Lea RA; Royds JA; Stubbs RS; Rooker S
    BMC Cancer; 2008 Jul; 8():187. PubMed ID: 18590575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KRAS Mutation-Responsive miR-139-5p inhibits Colorectal Cancer Progression and is repressed by Wnt Signaling.
    Du F; Cao T; Xie H; Li T; Sun L; Liu H; Guo H; Wang X; Liu Q; Kim T; Franklin JL; Graves-Deal R; Han W; Tian Z; Ge M; Nie Y; Fan D; Coffey RJ; Lu Y; Zhao X
    Theranostics; 2020; 10(16):7335-7350. PubMed ID: 32641995
    [No Abstract]   [Full Text] [Related]  

  • 31. Epigenetic drivers of tumourigenesis and cancer metastasis.
    Chatterjee A; Rodger EJ; Eccles MR
    Semin Cancer Biol; 2018 Aug; 51():149-159. PubMed ID: 28807546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma.
    Schofield HK; Zeller J; Espinoza C; Halbrook CJ; Del Vecchio A; Magnuson B; Fabo T; Cali Daylan AE; Kovalenko I; Lee HJ; Yan W; Feng Y; Karim SA; Kremer DM; Kumar-Sinha C; Lyssiotis CA; Ljungman M; Morton JP; Galbán S; Fearon ER; Pasca di Magliano M
    JCI Insight; 2018 Jan; 3(2):. PubMed ID: 29367463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation of driver and passenger mutations during tumor progression.
    Bozic I; Antal T; Ohtsuki H; Carter H; Kim D; Chen S; Karchin R; Kinzler KW; Vogelstein B; Nowak MA
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18545-50. PubMed ID: 20876136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An enhanced genetic model of colorectal cancer progression history.
    Yang L; Wang S; Lee JJ; Lee S; Lee E; Shinbrot E; Wheeler DA; Kucherlapati R; Park PJ
    Genome Biol; 2019 Aug; 20(1):168. PubMed ID: 31416464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further evidence that one of the earliest alterations in colorectal carcinogenesis involves APC.
    Tsao J; Shibata D
    Am J Pathol; 1994 Sep; 145(3):531-4. PubMed ID: 8080037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations of key driver genes in colorectal cancer progression and metastasis.
    Huang D; Sun W; Zhou Y; Li P; Chen F; Chen H; Xia D; Xu E; Lai M; Wu Y; Zhang H
    Cancer Metastasis Rev; 2018 Mar; 37(1):173-187. PubMed ID: 29322354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fundamental immune-oncogenicity trade-offs define driver mutation fitness.
    Hoyos D; Zappasodi R; Schulze I; Sethna Z; de Andrade KC; Bajorin DF; Bandlamudi C; Callahan MK; Funt SA; Hadrup SR; Holm JS; Rosenberg JE; Shah SP; Vázquez-García I; Weigelt B; Wu M; Zamarin D; Campitelli LF; Osborne EJ; Klinger M; Robins HS; Khincha PP; Savage SA; Balachandran VP; Wolchok JD; Hellmann MD; Merghoub T; Levine AJ; Łuksza M; Greenbaum BD
    Nature; 2022 Jun; 606(7912):172-179. PubMed ID: 35545680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis.
    He SY; Li YC; Wang Y; Peng HL; Zhou CL; Zhang CM; Chen SL; Yin JF; Lin M
    World J Gastroenterol; 2022 Jul; 28(25):2920-2936. PubMed ID: 35978873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mathematical modeling the order of driver gene mutations in colorectal cancer.
    Li L; Hu Y; Xu Y; Tang S
    PLoS Comput Biol; 2023 Jun; 19(6):e1011225. PubMed ID: 37368936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours.
    Weidlich S; Walsh K; Crowther D; Burczynski ME; Feuerstein G; Carey FA; Steele RJ; Wolf CR; Miele G; Smith G
    Br J Cancer; 2011 Jul; 105(2):246-54. PubMed ID: 21712828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.